======= ETFA =======
== Gene Information ==
* **Official Symbol**: ETFA
* **Official Name**: electron transfer flavoprotein subunit alpha
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2108|2108]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P13804|P13804]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ETFA&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ETFA|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/608053|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: ETFA participates in catalyzing the initial step of the mitochondrial fatty acid beta-oxidation. It shuttles electrons between primary flavoprotein dehydrogenases and the membrane-bound electron transfer flavoprotein ubiquinone oxidoreductase. Defects in electron-transfer-flavoprotein have been implicated in type II glutaricaciduria in which multiple acyl-CoA dehydrogenase deficiencies result in large excretion of glutaric, lactic, ethylmalonic, butyric, isobutyric, 2-methyl-butyric, and isovaleric acids. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Heterodimeric electron transfer flavoprotein that accepts electrons from several mitochondrial dehydrogenases, including acyl-CoA dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase (PubMed:27499296, PubMed:15159392, PubMed:15975918, PubMed:9334218, PubMed:10356313). It transfers the electrons to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) (PubMed:9334218). Required for normal mitochondrial fatty acid oxidation and normal amino acid metabolism (PubMed:12815589, PubMed:1882842, PubMed:1430199). {ECO:0000269|PubMed:10356313, ECO:0000269|PubMed:12815589, ECO:0000269|PubMed:1430199, ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918, ECO:0000269|PubMed:27499296, ECO:0000269|PubMed:9334218, ECO:0000303|PubMed:17941859, ECO:0000305|PubMed:1882842}.
|ETF alpha|
|ETF|
|fatty acid beta-oxidation using acyl-CoA dehydrogenase|
|flavin adenine dinucleotide binding|
|fatty acid beta-oxidation|
|electron transfer activity|
|fatty acid oxidation|
|lipid oxidation|
|fatty acid catabolic process|
|respiratory electron transport chain|
|monocarboxylic acid catabolic process|
|oxidoreductase activity|
|cellular respiration|
|electron transport chain|
|cellular lipid catabolic process|
|lipid modification|
|energy derivation by oxidation of organic compounds|
|organic acid catabolic process|
|carboxylic acid catabolic process|
|lipid catabolic process|
|fatty acid metabolic process|
|mitochondrial matrix|
|generation of precursor metabolites and energy|
|small molecule catabolic process|
|monocarboxylic acid metabolic process|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|organic acid metabolic process|
|lipid metabolic process|
|mitochondrion|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp462|Cadmium 60μM R08 exp462]]|1.79|
|[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|1.81|
|[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|1.82|
|[[:results:exp210|LB-100 2μM R05 exp210]]|1.91|
|[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|1.92|
|[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|1.94|
|[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.98|
|[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|2.01|
|[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|2.01|
|[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.05|
|[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|2.42|
|[[:results:exp234|Ethanol 0.01 R05 exp234]]|2.94|
^Gene^Correlation^
|[[:human genes:i:ivd|IVD]]|0.485|
|[[:human genes:e:etfb|ETFB]]|0.42|
|[[:human genes:h:hgc6.3|HGC6.3]]|0.405|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 17484
* **Expression level (log2 read counts)**: 7.33
{{:chemogenomics:nalm6 dist.png?nolink |}}